HuGE Literature Finder
Records
1
-
30
| Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles. Frontiers in oncology 2023 3 13 1120867. Deng Xinyue, Zhang Meilan, Wang Jiachen, Zhou Xiaoxi, Xiao M |
| Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study. Frontiers in oncology 2023 1 12 1062065. Chu Jinhua, Cai Huaju, Cai Jiaoyang, Bian Xinni, Cheng Yumei, Guan Xianmin, Chen Xiaoqian, Jiang Hua, Zhai Xiaowen, Fang Yongjun, Zhang Lei, Tian Xin, Zhou Fen, Wang Yaqin, Wang Lingzhen, Li Hong, Kwan Alex Leung Wing, Yang Minghua, Yang Hanfang, Zhan Aijun, Wang Ningling, Hu Shaoy |
| Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase. Clinical pharmacology and therapeutics 2022 Jul . Combes François Pierre, Li Ying Fei, Hoch Matthias, Lorenzo Sebastien, Ho Yu-Yun, Sy Sherwin K |
| The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients. Leukemia research 2022 Mar 114 106791. Park Hyunkyung, Kang Sungbong, Kim Inho, Kim Sangsoo, Kim Hyeong-Joon, Shin Dong-Yeop, Kim Dae-Young, Lee Kyoo-Hyung, Ahn Jae-Sook, Sohn Sang-Kyun, Lee Jeong-Ok, Cheong June-Won, Kim Kyoung Ha, Kim Hoon-Gu, Kim Hawk, Lee Yoo Jin, Nam Seung-Hyun, Do Young Rok, Park Sang-Gon, Park Seong Kyu, Song Hun Ho, Jung Chul Won, Park Seonya |
| ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. Leukemia 2022 7 36 (9): 2242-2249. Schönfeld Lioba, Rinke Jenny, Hinze Anna, Nagel Saskia N, Schäfer Vivien, Schenk Thomas, Fabisch Christian, Brümmendorf Tim H, Burchert Andreas, le Coutre Philipp, Krause Stefan W, Saussele Susanne, Safizadeh Fatemeh, Pfirrmann Markus, Hochhaus Andreas, Ernst Thom |
| BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
| Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes. Frontiers in oncology 2022 6 12 878098. Feng Jing, Guo Ye, Yang Wenyu, Zou Yao, Zhang Li, Chen Yumei, Zhang Yingchi, Zhu Xiaofan, Chen Xiaoju |
| Clinical characteristics, disease evolution and survival in patients with chronic myeloid leukemia, BCR-ABL1 (+) and T315I mutation. Folia medica 2022 7 63 (5): 670-675. Goranova-Marinova Veselina, Linev Alexander, Ivanov Hristo J, Zheljazkov Ivan, Stoyanova Vily, Grudeva-Popova Zhan |
| Differences in Variants in the Structural Domain of BCR-ABL1 Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing. Cytogenetic and genome research 2022 9 162 (4): 201-206. Abulaiti Dilinazi, Tuerxun Niluopaer, Wang Huan, Abulizi Patiguli, Zhao Fang, Liu Yang, Hao Jianpi |
| Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study. HemaSphere 2022 12 6 (12): e803. Yao Chi-Yuan, Agathangelidis Andreas, Chuang Shih-Sung, Tsou Hsiao-Hui, Feng Wei-Lien, Liu Ta-Chih, Chen Tsai-Yun, Yu Yuan-Bin, Yeh Su-Peng, Yao Ming, Wang Chuan-Cheng, Lin Johnson, Hwang Wen-Li, Gau Jyh-Pyng, Chou Wen-Chien, Chao Tsu-Yi, Lin Liang-In, Tien Hwei-Fang, Ghia Paolo, Wu Shang- |
| Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era. Experimental hematology & oncology 2022 3 11 (1): 13. Shi Ting, Xie Mixue, Chen Li, Yuan Wei, Wang Yungui, Huang Xin, Xie Wanzhuo, Meng Haitao, Lou Yinjun, Yu Wenjuan, Tong Hongyan, Ye Xiujin, Huang Jinyan, Jin Jie, Zhu Hong |
| Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in oncology 2022 12 952640. Madejczyk Anna Marta, Canzian Federico, Góra-Tybor Joanna, Campa Daniele, Sacha Tomasz, Link-Lenczowska Dorota, Florek Izabela, Prejzner Witold, Ca?becka M, Rymko M, Dudzi?ski M, Orzechowska Magdalena Julita, Jamroziak Krzyszt |
| Impact of Variants in the ATIC and ARID5B Genes on Therapeutic Failure with Imatinib in Patients with Chronic Myeloid Leukemia. Genes 2022 2 13 (2): . Cereja Pantoja Karla Beatriz Cardias, Azevedo Tereza Cristina de Brito, Carvalho Darlen Cardoso de, Monte Natasha, Cohen Paes Amanda de Nazaré, Barros Maria Clara da Costa, Vinagre Lui Wallacy Morikawa Souza, Freitas Ana Rosa Sales de, Burbano Rommel Mario Rodríguez, Assumpção Paulo Pimentel de, Santos Sidney Emanuel Batista Dos, Fernandes Marianne Rodrigues, Santos Ney Pereira Carneiro D |
| JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 842-846. Tarantini Francesco, Cumbo Cosimo, Zagaria Antonella, Parciante Elisa, Anelli Luisa, Coccaro Nicoletta, Tota Giuseppina, Minervini Crescenzio Francesco, Redavid Immacolata, Rossi Antonella Russo, Conserva Maria Rosa, Specchia Giorgina, Musto Pellegrino, Albano Frances |
| Lab tests for MPN. International review of cell and molecular biology 2022 2 366 187-220. Moncada Alice, Pancrazzi Alessand |
| Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report. Current oncology (Toronto, Ont.) 2022 11 29 (11): 8171-8179. Zhang Xupai, Sun Haoping, Su Yi, Yi H |
| Targeted Next-Generation Sequencing Identifies Additional Mutations Other than BCR?ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study. Cancers 2022 12 14 (23): . Hu Shiwei, Chen Dan, Xu Xiaofei, Zhang Lan, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Jin Jie, Huang Ji |
| The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation. Hematological oncology 2022 4 40 (3): 442-456. Shimazu Yutaka, Murata Makoto, Kondo Takeshi, Minami Yosuke, Tachibana Takayoshi, Doki Noriko, Uchida Naoyuki, Ozawa Yukiyasu, Yano Shingo, Fukuda Takahiro, Kato Jun, Ara Takahide, Eto Testuya, Ishikawa Jun, Nakamae Hirohisa, Tanaka Junji, Ichinohe Tatsuo, Atsuta Yoshiko, Nagamura-Inoue Tokiko, |
| Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients. Leukemia research 2021 Oct 111 106728. Park Hyunkyung, Kim Inho, Kim Hyeong-Joon, Shin Dong-Yeop, Lee Sung-Yeoun, Kwon Oh-Hyung, Kim Dae-Young, Lee Kyoo-Hyung, Ahn Jae-Sook, Park Jinny, Sohn Sang-Kyun, Lee Jeong-Ok, Cheong June-Won, Kim Kyoung Ha, Kim Hoon-Gu, Kim Hawk, Lee Yoo Jin, Nam Seung-Hyun, Do Young Rok, Park Sang-Gon, Park Seong Kyu, Bae Sung Hwa, Song Hun Ho, Oh Doyeun, Jung Chul Won, Park Seonya |
| Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors. Gene 2021 12 813 146101. Ismail Mohamed A, Nasrallah Gheyath K, Monne Maria, AlSayab Ali, Yassin Mohamed A, Varadharaj Govindarajulu, Younes Salma, Sorio Claudio, Cook Richard, Modjtahedi Helmout, Al-Dewik Nader |
| Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. Haematologica 2021 11 107 (9): 2051-2063. Creasey Thomas, Barretta Emilio, Ryan Sarra L, Butler Ellie, Kirkwood Amy A, Leongamornlert Daniel, Papaemmanuil Elli, Patrick Pip, Clifton-Hadley Laura, Patel Bela, Menne Tobias, McMillan Andrew K, Harrison Christine J, Rowntree Clare J, Morley Nick, Marks David I, Fielding Adele K, Moorman Anthony |
| Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update. Frontiers in genetics 2021 8 12 697009. Zhang Heyang, Liu Meng, Wang Xiaoxue, Ren Yuan, Kim Young Mi, Wang Xianfu, Lu Xianglan, Pang Hui, Liu Guangming, Gu Yue, Sun Mingran, Shi Yunpeng, Zhang Chuan, Zhang Yaowen, Zhang Jianqin, Li Shibo, Zhang Lij |
| High Expression of PKM2 Was Associated with the Poor Prognosis of Acute Leukemia. Cancer management and research 2021 13 7851-7858. Huang Yunxiu, Chen Lin-Mu, Xie Jin-Ye, Han Hui, Zhu Bao-Fang, Wang Luo-Jia, Wang Wei-J |
| High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood 2021 10 139 (10): 1557-1563. Kolijn P Martijn, Hosnijeh Fatemeh Saberi, Späth Florentin, Hengeveld Paul J, Agathangelidis Andreas, Saleh Manal, Casabonne Delphine, Benavente Yolanda, Jerkeman Mats, Agudo Antonio, Barricarte Aurelio, Besson Caroline, Sánchez Maria-Jose, Chirlaque María-Dolores, Masala Giovanna, Sacerdote Carlotta, Grioni Sara, Schulze Matthias B, Nieters Alexandra, Engelfriet Peter, Hultdin Magnus, McKay James D, Vermeulen Roel C H, Langerak Anton |
| IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial. Blood advances 2021 9 5 (17): 3322-3332. Mitchell Rachel J, Kirkwood Amy A, Barretta Emilio, Clifton-Hadley Laura, Lawrie Emma, Lee SooWah, Leongamornlert Daniel, Marks David I, McMillan Andrew K, Menne Tobias F, Papaemmanuil Elli, Patel Bela, Patrick Pip, Rowntree Clare J, Zareian Nahid, Alapi Krisztina Zuborne, Moorman Anthony V, Fielding Adele |
| Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? Mediterranean journal of hematology and infectious diseases 2021 11 13 (1): e2021062. Sora Federica, Chiusolo Patrizia, Autore Francesco, Giammarco Sabrina, Laurenti Luca, Innocenti Idanna, Metafuni Elisabetta, Galli Eugenio, Bacigalupo Andrea, Sica Simo |
| KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia. ImmunoHorizons 2021 8 5 (8): 687-702. Izumi Kiyotaka, Shindo Takero, Ngo Huong Thi, Nakayama-Hosoya Kaori, Akahane Koshi, Tamai Minori, Nguyen Thao T T, Kawana-Tachikawa Ai, Inukai Takeshi, Takaori-Kondo Akifu |
| The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome. Frontiers in oncology 2021 11 723722. Rodríguez-Caballero Arancha, Fuentes Herrero Blanca, Oliva Ariza Guillermo, Criado Ignacio, Alcoceba Miguel, Prieto Carlos, Pérez Caro María, García-Montero Andrés C, González Díaz Marcos, Forconi Francesco, Sarmento-Ribeiro Ana Bela, Almeida Julia, Orfao Alber |
| Thiol/Disulfide Balance in Older Patients with BCR-ABL Negative Myeloproliferative Neoplasms. Clinical laboratory 2021 12 67 (12): . Koyuncu Mahmut B, Cavusoglu Cagatay, Basir Hakan, Ilgan Mustafa, Ucar Mehmet A, Akdeniz Aydan, Tombak Anil, Tiftik Eyup N, Temel Gulhan O, Neselioglu Salim, Erel Ozc |
| Use of the «BCR/ABL - multitest» kit in the algorithm of laboratory diagnostics of oncohematological diseases: economic aspects. Klinicheskaia laboratornaia diagnostika 2021 9 66 (9): 571-576. Gorbenko A S, Stolyar M A, Vasiliev E V, Mikhalev M A, Bakhtina V I, Olkhovik T I, Mochalova E E, Orlova K E, Olkhovskiy I |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: